EC Status and Availability


EC ever use among women of reproductive age: 0.5% (DHS 2007)

EC knowledge among women of reproductive age: 9.3% (DHS 2007)

Contraceptive Use: 56.3% (DHS 2007, ever use of a modern method among women of reproductive age)

Registered LNG-EC products:

  • Lenor 72 - Available only with prescription
  • Pregnon - Available only with prescription
  • Revoke 72* - Available only with prescription

Products marked with * have been approved by a stringent regulatory authority, such as the WHO Prequalification Programme, the US Food and Drug Administration, the European Medicines Agency, or other.

Where at least one type of ECP is available: Public sector clinics, Pharmacies, IPPF-affiliated system

Age restrictions for accessing ECPs: No data available

Legal/regulatory documents in which EC is included: Essential Medicines List, Post-rape care guidelines

Other relevant information: EC distributed via IPPF outlets (500 - 1,000 in 2012).

In Zambia, the lowest cadre of health workers allowed to sell/dispense ECPs in the public sector is nurses, as of 2013. (USAID/DELIVER, Contraceptive Security Indicators, 2013)

In 2013, EC was procured by the government. No stock-outs were reported at the central level (JSI/Deliver data).

For more information, see below:

Our country-by-country information comes from numerous sources, including partners from around the world. We have made every effort to ensure that the information included here is correct, but EC availability and policies can change quickly. We welcome your additions and/or corrections

To submit updates and corrections to ICEC, click here.

Begin a new search